A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight

NCT07589686 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

486

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity or Overweight

Interventions

DRUG: Petrelintide
COMBINATION_PRODUCT: Enicepatide
DRUG: Petrelintide-matching Placebo
COMBINATION_PRODUCT: Enicepatide-matching Placebo

Sponsor

Hoffmann-La Roche

Collaborators

[object Object]